Home

Samsara BioCapital reported a 8.2% stake in Mineralys Therapeutics MLYS · 6,346,194 sh · amendment

Trade details

Type
5% stake report
Report
13D · amendment
Stake
8.2%
Last report
9.1% · filed 25/03/17
Shares held
6,346,194 sh
Class
Common Stock
Event date
25/09/04
Filed
25/09/08

8.2% stake · −0.9pp from the last report

Stake
8.2%
Last report
9.1%
Since last report
−0.9pp

Mineralys Therapeutics trades, last 26 weeks

What else happened in Mineralys Therapeutics around then

Filed or reported within 30 days of the trade day · 25/08/05~25/10/04

Samsara BioCapital's other 5% stake reports

  • Samsara BioCapital

    5% stakePMV Pharmaceuticals

    9.9% stake

    Filed 09/15

  • Samsara BioCapital

    5% stakeEloxx Pharmaceuticals

    9.9% stake

    Filed 08/14

  • Samsara BioCapital

    5% stakeRani Therapeutics Holdings

    9.9% stake

    Filed 05/28

  • Samsara BioCapital

    5% stakeKalaris Therapeutics

    54.2% stake

    Filed 05/22

  • Samsara BioCapital

    5% stakeSutro Biopharma

    6.4% stake

    Filed 05/15

Samsara BioCapital reported a 8.2% stake in Mineralys Therapeutics MLYS · 6,346,194 sh · amendment | Whalegun